These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4220076)

  • 21. [Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin].
    Makarevich NM; Mkrtchian SV; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):345-51. PubMed ID: 4321321
    [No Abstract]   [Full Text] [Related]  

  • 22. [Streptomycin and isoniazid resistance of strains of Mycobacterium tuberculosis isolated in Catania].
    Placenti A
    Lotta Tuberc; 1969; 39(4):264-74. PubMed ID: 4997375
    [No Abstract]   [Full Text] [Related]  

  • 23. [Resistance determination in practice in a tuberculosis clinic].
    ERMISCH K; ERMISCH U
    Zentralbl Bakteriol Orig; 1955 Dec; 164(8):566-76. PubMed ID: 13371902
    [No Abstract]   [Full Text] [Related]  

  • 24. Specialized transduction of tetracycline resistance by phage P22 in Salmonella typhimurium. I. Transduction of R factor 222 by phage P22.
    Watanabe T; Ogata Y; Chan RK; Botstein D
    Virology; 1972 Dec; 50(3):874-82. PubMed ID: 4565617
    [No Abstract]   [Full Text] [Related]  

  • 25. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cross-resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M; Toyama H; Mizuno S; Tsukamura S
    Kekkaku; 1967 Oct; 42(10):399-404. PubMed ID: 4295935
    [No Abstract]   [Full Text] [Related]  

  • 27. [STUDIES ON MYCOBACTERIOPHAGE AND ITS APPLICATION].
    TAKEYA K
    Fukuoka Igaku Zasshi; 1963 Oct; 54():1061-71. PubMed ID: 14110270
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical significance of resistance of Mycobacterium tuberculosis to chemoantibiotics].
    Lucchesi M; Zubiani M; Mancini P; Termine A
    Ann Ist Carlo Forlanini; 1967; 27(3):228-52. PubMed ID: 4972422
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
    Nagata A; Mase M; Yamamoto M; Nakamura H
    Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767
    [No Abstract]   [Full Text] [Related]  

  • 30. [Restoration of drug sensitivity in Mycobacterium tuberculosis to streptomycin and isoniazid during treatment with preparations of the 1st series].
    Rudoĭ NM; Utkin VV; Fedorova IE; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):355-7. PubMed ID: 4993044
    [No Abstract]   [Full Text] [Related]  

  • 31. [Drug resistance of Mycobacterium tuberculosis].
    Belousov AV; Donskova RA
    Lab Delo; 1975; (2):116-7. PubMed ID: 46313
    [No Abstract]   [Full Text] [Related]  

  • 32. Transduction in vibrio fetus.
    Chang W; Ogg JE
    Am J Vet Res; 1970 May; 31(5):919-24. PubMed ID: 5442454
    [No Abstract]   [Full Text] [Related]  

  • 33. Susceptibility of streptomycin-resistant Mycobacterium tuberculosis strains to amikacin.
    Hoffner SE; Källenius G
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):188-90. PubMed ID: 3134211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dynamics of drug resistance and restoration of sensitivity of Mycobacterium tuberculosis isolated from patients].
    Belogurova VP; Navrotskiĭ VV
    Antibiotiki; 1970 May; 15(5):434-7. PubMed ID: 4988018
    [No Abstract]   [Full Text] [Related]  

  • 35. Phage typing of strains of "M. tuberculosis" in the Netherlands.
    Engel HW
    Ann Sclavo; 1975; 17(4):578-83. PubMed ID: 820284
    [No Abstract]   [Full Text] [Related]  

  • 36. Rapid screening of Mycobacterium tuberculosis for susceptibility to rifampicin and streptomycin.
    McNerney R; Kiepiela P; Bishop KS; Nye PM; Stoker NG
    Int J Tuberc Lung Dis; 2000 Jan; 4(1):69-75. PubMed ID: 10654647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capreomycin laboratory studies.
    Bloom C
    Antibiot Chemother; 1970; 16():1-9. PubMed ID: 4108887
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies of the polychemoresistance of Mycobacterium tuberculosis].
    Curci G; De Franciscis V; Giuliano V
    Arch Monaldi; 1970; 25(2):99-114. PubMed ID: 4994908
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on the cross-resistance of Mycobacterium tuberculosis, strain H37Rv, to aminoglycoside- and peptide-antibiotics.
    Tsukamura M; Mizuno S
    Microbiol Immunol; 1980; 24(9):777-87. PubMed ID: 6783817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug resistance of Mycobacterium tuberculosis].
    Hori M; Yamada T
    Kekkaku; 1975 Dec; 50(11):416-9. PubMed ID: 815692
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.